Showing 281-300 of 389 for: Cochrane Systematic Reviews > Gynecologic 
- Progestagens and anti-progestagens for pain associated with endometriosis
Cochrane Systematic Reviews, 15-Feb-2012
Endometriosis is a chronic inflammatory condition defined by the presence of glands and stroma outside the uterine cavity. It occurs in 7% to 10% of all women of reproductive age and may present as pain or infertility. The pelvic pain may be in the form o
- Progesterone for premenstrual syndrome
Cochrane Systematic Reviews, 13-Mar-2012
About 5% of women experience severe symptoms called premenstrual syndrome (PMS), only in the two weeks before their menstrual periods. Treatment with progesterone may restore a deficiency, balance menstrual hormone levels or reduce effects of falling prog
- Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding
Cochrane Systematic Reviews, 28-Apr-2015
Heavy menstrual bleeding (HMB) is an important cause of ill health in women and it accounts for 12% of all gynaecology referrals in the UK. Heavy menstrual bleeding is clinically defined as greater than or equal to 80 mL of blood loss per menstrual cycle.
- Progestin-only contraceptives: effects on weight
Cochrane Systematic Reviews, 18-Jun-2013
Progestin-only contraceptives (POCs) are appropriate for many women who cannot or should not take estrogen. Many POCs are long-acting, cost-effective methods of preventing pregnancy. However, concern about weight gain can deter the initiation of contracep
- Progestin-only pills for contraception
Cochrane Systematic Reviews, 6-Nov-2013
The introduction of a new progestin-only oral contraceptive in Europe has renewed interest in this class of oral contraceptives. Unlike the more widely used combined oral contraceptives containing an estrogen plus progestin, these pills contain only a pro
- Progestogen for preventing miscarriage
Cochrane Systematic Reviews, 18-Oct-2013
Progesterone, a female sex hormone, is known to induce secretory changes in the lining of the uterus essential for successful implantation of a fertilized egg. It has been suggested that a causative factor in many cases of miscarriage may be inadequate se
- Progestogen for treating threatened miscarriage
Cochrane Systematic Reviews, 17-Oct-2011
Miscarriage is a common complication encountered during pregnancy. The role of progesterone in preparing the uterus for the implantation of the embryo and its role in maintaining the pregnancy have been known for a long time. Inadequate secretion of proge
- Progestogen-releasing intrauterine systems versus other forms of reversible contraceptives for contraception
Cochrane Systematic Reviews, 11-Jan-2010
Hormonally impregnated intrauterine systems (IUSs) add a progestogen to a non-medicated contraceptive device to improve contraceptive action.
- Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation
Cochrane Systematic Reviews, 12-Sep-2012
Irregular menstrual bleeding may arise due to exogenous sex steroids, lesions of the genital tract or be associated with anovulation. Irregular bleeding due to oligo/anovulation (previously called dysfunctional uterine bleeding or DUB) is more common at t
- Prophylactic antibiotics for transcervical intrauterine procedures
Cochrane Systematic Reviews, 31-May-2013
The transcervical intrauterine route is commonly used for operative gynaecological procedures in women. The vagina is an area of the body that is abundant with normal bacterial flora. An operative procedure through the vagina may, therefore, be considered
- Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery
Cochrane Systematic Reviews, 7-Mar-2014
Surgery has been used as part of breast cancer treatment for centuries; however any surgical procedure has the potential risk of infection. Infection rates for surgical treatment of breast cancer are documented at between 3% and 15%, higher than average f
- Prophylactic mastectomy for the prevention of breast cancer
Cochrane Systematic Reviews, 6-Oct-2010
Recent progress in understanding the genetic basis of breast cancer has increased interest in prophylactic mastectomy (PM) as a method of preventing breast cancer.
- Psychological interventions for women with metastatic breast cancer
Cochrane Systematic Reviews, 16-Jun-2015
Psychological symptoms are associated with metastatic breast cancer. This is the basis for exploring the impact of psychological interventions on psychosocial and survival outcomes. One early study appeared to show significant survival and psychological b
- Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome
Cochrane Systematic Reviews, 20-Sep-2010
In normal menstrual cycles, gonadotrophin releasing hormone (GnRH) secretion is pulsatile, with intervals of 60-120 minutes in the follicular phase. Treatment with pulsatile GnRH infusion by the intravenous or subcutaneous route using a portable pump has
- Quadriphasic versus monophasic oral contraceptives for contraception
Cochrane Systematic Reviews, 25-Oct-2011
Quadriphasic oral contraceptives have been developed to reduce the adverse effects of oral contraceptives and are presented as more physiological since they mimic the natural cycle. However, suggested disadvantages of quadriphasic oral contraceptives incl
- Radiotherapy and chemoradiation after surgery for early cervical cancer
Cochrane Systematic Reviews, 18-Apr-2012
This is an updated version of the original Cochrane review first published in Issue 4, 2009. There is an ongoing debate about the indications for, and value of, adjuvant pelvic radiotherapy after radical surgery in women with early cervical cancer. Certai
- Radiotherapy for early breast cancer
Cochrane Systematic Reviews, 5-Aug-2008
The long-term effects of radiotherapy on mortality from breast cancer and other causes remain uncertain.
- Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome
Cochrane Systematic Reviews, 24-Aug-2015
Gonadotrophins are known to be effective in inducing ovulation in women with clomiphene-resistant polycystic ovary syndrome. Ovulation induction with FSH bears the risk of multiple follicle development and multiple pregnancies. The dose regimen used can a
- Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles
Cochrane Systematic Reviews, 20-Sep-2010
During in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycles, controlled ovarian hyperstimulation (COH) is performed with recombinant follicle stimulating hormone (rFSH) in combination with a gonadotrophin-releasing hormone
- Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles
Cochrane Systematic Reviews, 18-Jan-2011
Until recently, the main source of exogenous follicle stimulating hormone (FSH) for therapeutic use in infertility had been the urine of postmenopausal women. New developments have resulted in the production of FSH in vitro by recombinant DNA technology.
